Published in Medical Letter on the CDC and FDA, May 2nd, 2010
The meeting is scheduled for 9 a.m. to 5 p.m. at the Hilton Washington, D.C./Rockville Hotel and Executive Meeting Center in Rockville, Md.
The current legislative authority for PDUFA (PDUFA IV), reauthorized in 2007 by the FDA Amendments Act, will expire in September 2012. The FDA scheduled the meeting to gather input from stakeholders before the agency begins discussions with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.